Podcast

A Potential Pharmacologic Treatment for OSA

06/24/2022

A new study analyzed how a combination of atomoxetine and oxybutynin affects obstructive sleep apnea (OSA) severity. In this podcast, one of the study’s authors, Luigi Taranto-Montemurro, MD, from Harvard Medical School and Brigham and Women's Hospital, provides insight on his findings and what they mean for the future of pharmacotherapy for OSA.

Luigi Taranto-Montemurro, MD, is an instructor in medicine at Harvard Medical School. He is also an associate scientist in the Division of Sleep and Circadian Disorders, Department of Medicine, at Brigham and Women's Hospital.

Additional Resource:

Taranto-Montemurro L, Messineo L, Sands SA, et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial. Am J Respir Crit Care Med. 2019;199(10). doi:10.1164/rccm.201808-1493OC. 

Related Content

Multiple Sclerosis
Multiple Sclerosis
Patricia K. Coyle, MD, on Progressive Multiple Sclerosis
07/23/2020
In this podcast, Dr Coyle reviews the diagnosis and clinical course of progressive multiple sclerosis (MS), pearls for distinguishing it from its differential diagnosis, and the importance of...
07/23/2020
Sexually Transmitted Infections and Diseases
Sexually Transmitted Infections and Diseases
Jodie Dionne-Odom, MD, on the Predictors of Syphilis in the United States
04/18/2019
Jodie Dionne-Odom, MD, from the University of Alabama at Birmingham, discusses her research "Incident Syphilis Rates and Predictors in US Women With HIV, 2005-2016."
04/18/2019
Stress and Burnout
Stress and Burnout
Sarah Piraino, PharmD, on Diabetes and COVID-19
10/27/2011
In this podcast, Sarah Piraino, PharmD, speaks about glycemic outcomes in people with diabetes in the presence or absence of COVID-19 infection, including gaps that exist in the research and future...
10/27/2011
Cardiometabolic Risk
Cardiometabolic Risk
Mary Ann Hodorowicz, RDN, CDE, on Coding for Reimbursement
10/25/2019
Mary Ann Hodorowicz, RDN, CDE, gives a preview of her upcoming Cardiometabolic Risk Summit talk on what clinicians can do to provide high-quality outpatient services related to cardiometabolic health, as...
10/25/2019
Cardiovascular Diseases
Cardiovascular Diseases
Peter H. Jones, MD, on Treating Dyslipidemia: a Preview
11/03/2020
In this podcast, Peter Jones, MD, gives a preview of his presentation on the prevention of cardiovascular disease and the treatment of dyslipidemia, which will be presented at the Practical Updates in...
11/03/2020